Constellation Pharmaceuticals' Series B - IV Round

Constellation Pharmaceuticals raised a round of funding on August 05, 2014.

Constellation Pharmaceuticals is a biopharmaceutical company dedicated to the development of therapeutics in the emerging field of Epigenetics, a new field of science involving selective regulators th…

Articles about Constellation Pharmaceuticals' Series B - IV Round: